Increased risks between Interleukin-10 gene polymorphisms and haplotype and head and neck cancer: A meta-analysis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Niu, Yu Ming ^a   Du, Xin Ya ^b   Cai, Heng Xing ^c   Zhang, Chao ^a   Yuan, Rui Xia ^a   Zeng, Xian Tao ^a,c   Luo, Jie ^a  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

^b People s Hospital of Longhua   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IL10 PROTEIN, HUMAN; INTERLEUKIN 10;

ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CAUCASIAN; ETHNOLOGY; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HEAD AND NECK NEOPLASMS; HUMAN; IMMUNOLOGY; META ANALYSIS; ODDS RATIO; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEAD AND NECK NEOPLASMS; HUMANS; INTERLEUKIN-10; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84948460065     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17149     Document Type: Article

References (51)

1. Argiris, A., Karamouzis, M. V., Raben, D., & Ferris, R. L. Head and neck cancer. Lancet 371, 1695-1709 (2008
2. Argiris, A., & Eng, C. Epidemiology, staging, and screening of head and neck cancer. Cancer Treat Res 114, 15-60 (2003
3. Siegel, R., Ma, J., Zou, Z., & Jemal, A. Cancer statistics, 2014. CA Cancer J Clin 64, 9-29 (2014
4. Pulte, D., & Brenner, H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist 15, 994-1001 (2010
5. Ndiaye, C., et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and metaanalysis. Lancet Oncol 15, 1319-1331 (2014
6. Hashibe, M., et al. Evidence for an important role of alcohol-And aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 15, 696-703 (2006
7. Vineis, P., et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 96, 99-106 (2004
8. Ramqvist, T., Grun, N., & Dalianis, T. Human Papillomavirus and Tonsillar and Base of Tongue Cancer. Viruses 7, 1332-1343 (2015
9. Perry, B. J., et al. Sites of origin of oral cavity cancer in nonsmokers vs smokers: possible evidence of dental trauma carcinogenesis and its importance compared with human papillomavirus. JAMA Otolaryngol Head Neck Surg 141, 5-11 (2015
10. Li, Q., et al. Vitamin or mineral supplement intake and the risk of head and neck cancer: pooled analysis in the INHANCE consortium. Int J Cancer 131, 1686-1699 (2012
11. Coussens, L. M., & Werb, Z. Inflammation and cancer. Nature 420, 860-867 (2002
12. Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30, 1073-1081 (2009
13. Niu, Y., et al. Association between cyclooxygenase-2 gene polymorphisms and head and neck squamous cell carcinoma risk. J Craniofac Surg 25, 333-337 (2014
14. Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19, 683-765 (2001
15. De Vries, J. E. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med 27, 537-541 (1995
16. Howell, W. M., & Rose-Zerilli, M. J. Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J Nutr 137, 194S-199S (2007
17. Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170, 2081-2095 (1989
18. Moore, K. W., et al. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248, 1230-1234 (1990
19. Eskdale, J., Kube, D., Tesch, H., & Gallagher, G. Mapping of the human IL10 gene and further characterization of the 5 flanking sequence. Immunogenetics 46, 120-128 (1997
20. Kingo, K., et al. Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. J Dermatol Sci 37, 111-113 (2005
21. Turner, D. M., et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24, 1-8 (1997
22. Saxena, M., Agrawal, C. C., Bid, H. K., & Banerjee, M. An interleukin-10 gene promoter polymorphism (-592A/C) associated with type 2 diabetes: a North Indian study. Biochem Genet 50, 549-559 (2012
23. Eskdale, J., et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 95, 9465-9470 (1998
24. Gibson, A. W., et al. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166, 3915-3922 (2001
25. Pooja, S., et al. Polymorphic variations in IL-1beta, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women. Cytokine 60, 122-128 (2012
26. Hsia, T. C., et al. Interleukin-10 (IL-10) promoter genotypes are associated with lung cancer risk in Taiwan males and smokers. Anticancer Res 34, 7039-7044 (2014
27. Singhal, P., Kumar, A., Bharadwaj, S., Hussain, S., & Bharadwaj, M. Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma. Tumour Biol 36, 2287-2298 (2015
28. Kuo, W. H., et al. Effects of interleukin-10 polymorphisms and smoking on the risk of gastric cancer in Taiwan. In Vivo 28, 967-971 (2014
29. Pratesi, C., et al. Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 55, 23-30 (2006
30. Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. BMJ 339, b2535 (2009
31. Qiao, H., et al. Association between heme oxygenase 1 gene promoter polymorphisms and susceptibility to coronary artery disease: a HuGE review and meta-Analysis. Am J Epidemiol 179, 1039-1048 (2014
32. Thakkinstian, A., et al. Systematic review and meta-Analysis of the association between {beta}2-Adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162, 201-211 (2005
33. DerSimonian, R., & Laird, N. Meta-Analysis in clinical trials. Control Clin Trials 7, 177-188 (1986
34. Mantel, N., & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22, 719-748 (1959
35. Song, F., Khan, K. S., Dinnes, J., & Sutton, A. J. Asymmetric funnel plots and publication bias in meta-Analyses of diagnostic accuracy. Int J Epidemiol 31, 88-95 (2002
36. Huedo-Medina, T. B., Sanchez-Meca, J., Marin-Martinez, F., & Botella, J. Assessing heterogeneity in meta-Analysis: Q statistic or I2 index?. Psychol Methods 11, 193-206 (2006
37. Wei, Y. S., et al. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma. Tissue Antigens 70, 12-17 (2007
38. Farhat, K., Hassen, E., Gabbouj, S., Bouaouina, N., & Chouchane, L. Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma. Int J Immunogenet 35, 197-205 (2008
39. Yao, J. G., Gao, L. B., Liu, Y. G., Li, J., & Pang, G. F. Genetic variation in interleukin-10 gene and risk of oral cancer. Clin Chim Acta 388, 84-88 (2008
40. Vairaktaris, E., et al. The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma. Anticancer Res 28, 309-314 (2008
41. Jeong, S. W., et al. Cox-2 and IL-10 polymorphisms and association with squamous cell carcinoma of the head and neck in a Korean sample. J Korean Med Sci 25, 1024-1028 (2010
42. Tsai, C. W., et al. Association of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan. Anticancer Res 33, 3391-3396 (2013
43. Tsai, C. W., et al. Significant association of Interleukin-10 genotypes and oral cancer susceptibility in Taiwan. Anticancer Res 34, 3731-3737 (2014
44. Hsu, H. J., et al. TGF-beta1 and IL-10 single nucleotide polymorphisms as risk factors for oral cancer in Taiwanese. Kaohsiung J Med Sci 31, 123-129 (2015
45. Lengauer, C., Kinzler, K. W., & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643-649 (1998
46. Marshall, H. Genetic and epigenetic factors in development of lung cancer. Lancet Oncol 13, 1188 (2012
47. Germano, G., Allavena, P., & Mantovani, A. Cytokines as a key component of cancer-related inflammation. Cytokine 43, 374-379 (2008
48. Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res 2014, 149185 (2014
49. Grivennikov, S. I., Greten, F. R., & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883-899 (2010
50. Ma, L., et al. A pooled analysis of the IL-10-1082 A/G polymorphism and the nasopharyngeal carcinoma susceptibility. Eur Arch Otorhinolaryngol, doi: 10.1007/s00405-014-3465-9 (2014
51. Zeng, X., et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and metaanalysis, and clinical practice guideline: a systematic review. J Evid Based Med 8, 2-10 (2015